Advertisement

Common hepatic lipase gene promoter variant predicts the degree of neointima formation after carotid endarterectomy: Impact of plaque composition and lipoprotein phenotype

      Abstract

      Background

      The common −514 C-T promoter polymorphism of the hepatic lipase gene (LIPC) and the cholesteryl ester transfer protein (CETP) gene TaqIB polymorphism affect atherogenesis. We investigated the potential relationship between these polymorphisms and the maximum-intima-media thickness (M-IMT) after carotid endarterectomy.

      Methods

      The LIPC and CETP genotypes were determined by PCR in 68 patients undergoing endarterectomy. Plaque specimens were analysed for cell composition by immunocytochemistry. Six month after surgery the M-IMT of the revascularized vessel was assessed by B-mode ultrasonography.

      Results

      The CC carriers had denser LDL particles (p < 0.0005), an abundance of macrophages (p < 0.0005), fewer SMCs in the carotid plaque (p < 0.0005), and higher prevalence of cerebrovascular events (72% versus 28%, p = 0.002) compared to CT/TT carriers. After endarterectomy, CC carriers showed a lower M-IMT than the CT/TT group (1.36 mm versus 1.76 mm, p = 0.04). No association between the CETP polymorphism and either carotid plaque cellular composition or M-IMT was observed. In a multivariate analysis, M-IMT was associated with plaque cell composition (macrophages, r = −0.39; SMC, r = 0.44; p < 0.005 for both) but not with pre-operative LDL-C, HDL-C, triglycerides, or LDL density.

      Conclusions

      The LIPC promoter −514 C-T polymorphism is associated with a significantly reduced development of neointima after surgery. This effect seems to be mediated by scarcity of SMC in the plaque of CC carriers who display an excess prevalence of cerebrovascular events prior endarterectomy but are at low risk for restenosis. The pre-operative lipid phenotype plays a marginal role in the neointima formation.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Moore W.S.
        • Kempczinski R.F.
        • Nelson J.J.
        • et al.
        Recurrent carotid stenosis. Results of the asymptomatic carotid atherosclerosis study.
        Stroke. 1998; 29: 2018-2025
        • Libby P.
        • Ganz P.
        Restenosis revisited-new targets, new therapies (editorial).
        N Engl J Med. 1997; 337: 418-419
        • Leclerc G.
        • Isner J.M.
        • Kearney M.
        • et al.
        Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy.
        Circulation. 1992; 85: 543-553
        • Simons M.
        • Leclerc G.
        • Safian R.D.
        • et al.
        Relation between activated smooth-muscle cells in coronary-artery lesions and restenosis after atherectomy.
        N Engl J Med. 1993; 328: 608-613
        • Aikawa M.
        • Sakomura Y.
        • Ueda M.
        • et al.
        Redifferentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression.
        Circulation. 1997; 96: 82-90
        • Pauletto P.
        • Puato M.
        • Faggin E.
        • et al.
        Specific cellular features of atheroma associated with development of neointima after carotid endarterectomy: the Carotid Atherosclerosis and Restenosis Study.
        Circulation. 2000; 102: 771-778
        • Zannad F.
        • Athanase B.
        Genetics of intima-media thickness.
        Curr Opin Lipidol. 2003; 14: 191-200
        • Humphries S.E.
        • Morgan L.
        Genetic risk factoirs for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches.
        Lancet Neurol. 2004; 3: 227-236
        • Zambon A.
        • Deeb S.S.
        • Hokanson J.E.
        • et al.
        Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol.
        Arterioscler Thromb Vasc Biol. 1998; 18: 1723-1729
        • Isaacs A.
        • Sayed-Tabatabaei F.A.
        • Njajou O.T.
        • et al.
        The −514C to T Hepatic Lipase promoter region polymorphism and plasma lipids: a meta-analysis.
        J Clin Endocrinol Metab. 2004; 89: 3858-3863
        • Faggin E.
        • Zambon A.
        • Puato M.
        • et al.
        Association between the CC genotype of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis.
        J Am Coll Cardio. 2002; 40: 1059-1066
        • Kuivenhoven J.A.
        • Jukema J.W.
        • Zwinderman A.H.
        • et al.
        • The Regression Growth Evaluation Statin Study Group
        The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis.
        N Engl J Med. 1998; 338: 86-93
        • de Grooth G.J.
        • Zerba K.E.
        • Huang S-P.
        • Tsuchihashi Z.
        • Kirchgessner T.
        • et al.
        The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the Cholesterol and Recurrent Events Study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome.
        J Am Coll Cardiol. 2004; 43: 854-857
        • Rundek T.
        • Elkind M.S.
        • Pittman J.
        • et al.
        Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study.
        Stroke. 2002; 33: 1420-1423
        • Zambon A.
        • Austin M.A.
        • Brown B.G.
        • et al.
        Effect of hepatic lipase on LDL in normal men and those with coronary artery disease.
        Arterioscler Thromb. 1993; 13: 147-153
        • Clagett G.P.
        • Rich N.M.
        • McDonald P.T.
        • et al.
        Etiologic factors for recurrent carotid artery stenosis.
        Surgery. 1983; 93: 313-318
        • Ouriel K.
        • Green R.M.
        Clinical and technical factors influencing recurrent carotid stenosis and occlusion after endarterectomy.
        J Vasc Surg. 1987; 5: 702-706
        • Pauletto P.
        • Sartore S.
        • Pessina A.C.
        Smooth-muscle-cell proliferation and differentiation in neointima formation and vascular restenosis.
        Clin Sci. 1994; 87: 467-479
        • Pauletto P.
        • Palatini P.
        • Da Ros S.
        • et al.
        Factors underlying the increase in carotid intima-media thickness in borderline hypertensives.
        Arterioscler Thromb Vasc Biol. 1999; 19: 1231-1237
        • Tardif J.C.
        • Gregoire J.
        • Lavoie M.A.
        • et al.
        Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies.
        Curr Opin Lipidol. 2003; 14: 615-620
        • Jensen H.
        • Verhoeven A.M.
        • Weeks L.
        • Kastelein J.P.
        • Halley D.J.
        • Vandenouweland A.
        • et al.
        Common C-to-T substitution at position −480 of the hepatic lipase promoter associated with a lowered hepatic lipase activity in coronary artery disease patients.
        Arterioscler Thromb Vasc Biol. 1997; 17: 2837-2842
        • Libby P.
        Molecular bases of the acute coronary syndromes.
        Circulation. 1995; 91: 2844-2850
        • Austin M.A.
        • Breslow J.L.
        • Hennekens C.H.
        • et al.
        Low-density lipoprotein subclass patterns and risk of myocardial infarction.
        JAMA. 1988; 260: 1917-1921
        • Chait A.
        • Brazg R.L.
        • Tribble D.L.
        • et al.
        Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B.
        Am J Med. 1993; 94: 350-356
        • Martens A.
        • Halvoet P.
        Oxidized LDL and HDL: antagonists in atherothrombosis.
        FASEB J. 2001; 15: 2073-2084
        • Theilmeier G.
        • Quarck R.
        • Verhamme P.
        • et al.
        Hypercholesterolemia impairs vascular remodelling after porcine coronary angioplasty.
        Cardiovas Res. 2002; 55: 385-395
        • Nilsson J.
        • Calara F.
        • Regnstrom J.
        • et al.
        Immunization with homologous oxidized low-density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits.
        J Am Coll Cardiol. 1997; 30: 1886-1891
        • Schober A.
        • Bernhagen J.
        • Thiele M.
        • et al.
        Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein e-deficient mice.
        Circulation. 2004; 109: 380-385
        • Sattar N.
        • Petrie J.R.
        • Jaap A.J.
        The atherogenic lipoprotein phenotype and vascular endothelial dysfunction.
        Atherosclerosis. 1998; 138: 229-235
        • Pihlajamaki J.
        • Karjalainen L.
        • Karhapaa P.
        • et al.
        G-250A Substitution in the promoter of the hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia.
        Arterioscler Thromb Vasc Biol. 2000; 20: 1789-1795
        • Todorova B.
        • Kubaszek A.
        • Pihlajamaki J.
        • Lindstrom J.
        • Eriksson J.
        • Valle T.T.
        • et al.
        The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the finnish diabetes prevention study.
        J Clin Endocrinol Metab. 2004; 89: 2019-2023